Key Insights

Highlights

Success Rate

89% trial completion (above average)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 40/100

Termination Rate

4.8%

2 terminated out of 42 trials

Success Rate

88.9%

+2.4% vs benchmark

Late-Stage Pipeline

12%

5 trials in Phase 3/4

Results Transparency

19%

3 of 16 completed with results

Key Signals

3 with results89% success

Data Visualizations

Phase Distribution

29Total
Not Applicable (14)
Early P 1 (3)
P 1 (2)
P 2 (5)
P 3 (1)
P 4 (4)

Trial Status

Completed16
Unknown14
Recruiting7
Terminated2
Not Yet Recruiting1
Withdrawn1

Trial Success Rate

88.9%

Benchmark: 86.5%

Based on 16 completed trials

Clinical Trials (42)

Showing 20 of 20 trials
NCT03864068Phase 2Completed

Inositol Supplementation to Treat PCOS (INSUPP-PCOS)

NCT07253454Not Yet RecruitingPrimary

Combined Use of Machine Learning and Metabolomics to Improve the Diagnosis and Management of Hyperandrogenism

NCT06889454Recruiting

Cardiovascular and Endothelial Markers During OGTT Before and at Six and Twelve Months Post-treatment in Women With PCOS

NCT00929006Early Phase 1Recruiting

Acute Progesterone Suppression of Wake vs. Sleep Luteinizing Hormone Pulse Frequency in Pubertal Girls With and Without Hyperandrogenism

NCT04723862Early Phase 1RecruitingPrimary

Does Spironolactone Normalize Sleep-wake Luteinizing Hormone Pulse Frequency in Pubertal Girls With Hyperandrogenism?

NCT03068910Early Phase 1RecruitingPrimary

Hyperandrogenemia and Altered Day-night LH Pulse Patterns

NCT04979377Completed

Prevalence of Hyperandrogenism in Type 1 Diabetes

NCT02647827Phase 2Recruiting

Acupuncture or Metformin for Insulin Resistance in Women With PCOS

NCT04912648RecruitingPrimary

FEmale Metabolic Risk and Androgens: an Irish Longitudinal (FEMAIL) Study

NCT02523898Phase 2Terminated

Metformine and CC Compared With Placebo and CC for Induction Ovulation in PCOS Patients With Insulin Resistant

NCT03742011Recruiting

Offspring Born to Mothers With Polycystic Ovary Syndrome in Guangzhou Cohort Study

NCT01428089Phase 1Unknown

Suppression of Daytime and Nighttime Luteinizing Hormone Frequency by Progesterone

NCT02155933Unknown

Assessment of Day-night Secretion of Progesterone and LH Across Puberty

NCT02611128Suspended

Urinary DENND1A.V2 as a Predictor of Pubertal Hyperandrogenemia

NCT01421810Not ApplicableUnknown

Ovarian Contribution to Androgen Production in Adolescent Girls

NCT05926115Unknown

Phenotype and Epidemiology of the Polycystic Ovary Syndrome (PCOS) in Colombia (PEP - Colombia) Study.

NCT04524325Not ApplicableWithdrawn

Mechanisms of Blood Pressure Dysfunction in Transmen Receiving Testosterone

NCT02460445Not ApplicableCompletedPrimary

Phlebotomy and Polycystic Ovary Syndrome

NCT00930007UnknownPrimary

Sleep-wake Changes of Luteinizing Hormone Frequency in Pubertal Girls With and Without High Testosterone

NCT03902301Not ApplicableCompleted

Lactobacillus Rhamnosus and PCOS Treatment

Scroll to load more

Research Network

Activity Timeline